Send to

Choose Destination
See comment in PubMed Commons below
Am J Cardiol. 2005 Nov 7;96(9A):14K-19K; discussion 34K-35K. Epub 2005 Sep 12.

Rationale for targeting multiple lipid pathways for optimal cardiovascular risk reduction.

Author information

Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart Center, Houston, Texas, USA.


Clinical trials of statin therapy have consistently demonstrated significant reductions in coronary artery disease (CAD) events, yet statin-treated patients remain at risk for CAD despite substantial reductions in low-density lipoprotein (LDL) cholesterol. Recent evidence from clinical trials supports reduction of LDL cholesterol to lower targets, and the updated treatment guidelines include optional, more aggressive LDL cholesterol goals for patients at very high and moderately high risk. Achievement of these lower goals will require enhanced treatment strategies. Targeting multiple lipid pathways can provide greater reductions in LDL cholesterol as well as improvements in other lipid parameters. Clinical trials are needed to determine which treatment strategies provide optimal cardiovascular risk reduction.

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center